General Information of Drug (ID: DMJSMDL)

Drug Name
Cefiderocol
Synonyms Cephalosporin, GSK2696266; S-649266
Indication
Disease Entry ICD 11 Status REF
Hospital-acquired pneumonia CA40.Z Approved [1]
Urinary tract infection GC08 Approved [1]
Ventilator-associated pneumonia PK81.0 Approved [1]
Healthcare-associated pneumonia CA00-CA40 Phase 3 [2]
Affected Organisms
Pseudomonas aeruginosaEscherichia coliAcinetobacter baumanniiKlebsiella pneumoniaeSerratia marcescensStenotrophomonas maltophiliaAcinetobacter calcoaceticusAcinetobacter haemolyticusAcinetobacter johnsoniiAcinetobacter lwoffiiAeromonas hydrophilaCampylobacter jejuniElizabethkingia meningosepticaEnterobacter cloacaeHaemophilus influenzaeKlebsiella oxytocaMoraxella catarrhalisMorganella morganiiNeisseria gonorrhoeaeNeisseria meningitidisProteus mirabilisProteus vulgarisProvidencia rettgeriCitrobacter freundiiProvidencia stuartiiPseudomonas putidaPseudomonas stutzeriSalmonella enteritidisSalmonella paratyphiSalmonella typhiSalmonella typhimuriumSalmonella choleraesuisShigella flexneriYersinia enterocoliticaVibrio vulnificusVibrio fluvialisMicrococcus luteusStreptococcus pneumoniaeStreptococcus pyogenesYersinia pseudotuberculosis
ATC Code
J01DI04: Cefiderocol
J01DI: Other cephalosporins and penems
J01D: OTHER BETA-LACTAM ANTIBACTERIALS
J01: ANTIBACTERIALS FOR SYSTEMIC USE
J: ANTIINFECTIVES FOR SYSTEMIC USE
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C30H34ClN7O10S2
Canonical SMILES
CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4(CCCC4)CCNC(=O)C5=C(C(=C(C=C5)O)O)Cl)C(=O)[O-]
InChI
1S/C30H34ClN7O10S2/c1-30(2,28(46)47)48-36-19(16-13-50-29(32)34-16)24(42)35-20-25(43)37-21(27(44)45)14(12-49-26(20)37)11-38(8-3-4-9-38)10-7-33-23(41)15-5-6-17(39)22(40)18(15)31/h5-6,13,20,26H,3-4,7-12H2,1-2H3,(H7-,32,33,34,35,36,39,40,41,42,44,45,46,47)/t20-,26-/m1/s1
InChIKey
DBPPRLRVDVJOCL-FQRUVTKNSA-N
Cross-matching ID
PubChem CID
77843966
CAS Number
1225208-94-5
UNII
SZ34OMG6E8
DrugBank ID
DB14879
TTD ID
D0Q7MA
Combinatorial Drugs (CBD) Click to Jump to the Detailed CBD Information of This Drug
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2020
2 ClinicalTrials.gov (NCT02714595) Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens (CREDIBLE - CR). U.S. National Institutes of Health.